M2D2 Foundations for Success: What to Think About Now to Prepare for the Future
Thursday, November 6, 2014
6-9 p.m.
Join us for a panel presentation and discussion presented by Sheehan Phinney Bass + Green PA. Attorney’s from Sheehan Phinney will present a range of legal and financial strategies for promoting the development and launch of your medical device startup. Topics to be discussed include the following:
John H. Perten, Moderator
John acts as outside general counsel to several established and emerging businesses. His background as a business attorney and business litigator gives him a unique perspective on issues common to start-ups and those working towards bringing their products to market, developing strategy for growth, and (for some) exploration of exit strategies. He has a working knowledge of each of the issues to be discussed in this presentation
Equity in Lieu of Salary
Many start-ups that are cash poor would like to be able to offer their employees and consultants equity in lieu of salary or other remuneration. A number of legal issues can arise out of the use of stock, options or other equity-based arrangements to compensate personnel, however, including minimum wage requirements, vesting considerations, voting rights and securities laws. We will discuss these issues and some practical solutions for addressing them.
Presented by Alexander Pyle, Corporate Department Chair.
Patent Considerations for the Medical Device Start-Ups
A number of patent-related issues are particularly germane to the medical technology start-up community. This will touch on several of these issues, including, for example, the tension between the FDA approval process and obtaining strong patent protection, strategies for effectively protecting evolving technologies, options for expediting the patent process, and patent filing strategies in view of the US’s recent shift from a first-to-invent patent system to a firs-inventor-to-file patent system.
Presented by William O’Sullivan, Patent Attorney.
Life Sciences Tax Incentive Program
In 2008, the Governor signed an Act “to expand employment in the life sciences sector in Massachusetts and to promote health-related innovations by supporting research, development, manufacturing and commercialization in the sciences.” (TIR 08-23). The Act offers specialized tax benefits to qualifying companies. These include investment tax credits to personal income tax and corporate excise tax equal to 10% of the cost of qualifying property acquired, constructed, reconstructed, or erected in Massachusetts, as well a host of other tax benefits to a qualified life sciences company. We will explore the tax benefits available and discuss the process by which one qualifies.
Presented by Russell Stein, Tax Attorney.
Investment Vehicles for Immigrant Investors
The United States provides a host of avenues for foreign persons to immigrate to this country. These include family-based, employment-based, and merit-based processes. In recent years, the investor-based immigration process, known as "employment-based, fifth preference ("EB-5" for short), has gained in popularity. Using the EB-5 program, immigrant investors are able to trade qualifying, "job-creation" investments in U.S. businesses for permanent residence. This program will cover how U.S. businesses are using EB-5 investment capital, what investments qualify for EB-5 immigration, and the application process itself.
Presented by Nathan Warecki, Immigration Attorney.
This event will be held at the Massachusetts Medical Device Development Center (M2D2), 600 Suffolk Street, Lowell MA 01854
Registration Fee until October 24, 2014: $10
Registration Fee after October 24, 2014: $20
Day of Event/Walk-in/On-site Registration Fee: $30
Registration fee includes pizza, beer & wine.
M2D2 would like to thank the following event sponsor.